Table 1. Pharmacokinetic Parameters of Caffeine after Oral Administration as Alone (Group I) and Intravenous Administration of Pinocembrin Followed by Oral Administration of Caffeine (Group II) in Ratsa.
caffeine |
||
---|---|---|
pharmacokinetic parameters | group I (alone) | group II (with pinocembrin) |
Cmax (ng/mL) | 1063 ± 102 | 1319 ± 140 |
Tmax (h) | 0.7 ± 0.1 | 1.1 ± 0.2 |
AUC0–t (ng·h/mL) | 2838 ± 141 | 4629 ± 409** |
AUC0–∞ (ng·h/mL) | 2851 ± 139 | 4864 ± 407** |
T1/2 (h) | 1.1 ± 0.1 | 0.8 ± 0.1 |
Vd/F (L/kg) | 8.4 ± 1.2 | 4.1 ± 0.9* |
Cl/F (L/h/kg) | 5.3 ± 0.3 | 3.3 ± 0.3*** |
Data are presented as the mean ± SEM (n = 5). *p < 0.05, **p < 0.01, and ***p < 0.001 denote statistical significance when compared between group I versus group II. Cmax, the highest plasma concentration; Tmax, the time to reach Cmax; AUC0–t, the area under the curve for plasma concentrations from zero to the last measurable plasma sample time; AUC0–∞, the area under the curve for plasma concentrations from zero to infinity; T1/2, elimination half-life; Vd/F, the volume of distribution after oral administration; Cl/F, clearance after oral administration.